Erratum: Toxins in anti-nociception and anti-inflammation (Toxicon Review (2004) 44 (1-17) DOI: 10.1016/j.toxicon.2004.04.014);Toxins in anti-nociception and anti-inflammation

Toxicon

Volumn 44, Issue 1, 2004, Pages 1-17

  Rajendra, Wudayagiri ^a,b   Armugam, Arunmozhiarasi ^a   Jeyaseelan, Kandiah ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SRI VENKATESWARA UNIVERSITY   (India)

Author keywords

Inflammation; Nociception; Therapeutics; Venoms

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; COBROTOXIN; CONANTOKIN G; CONOTOXIN; CONTULAKIN G; CROTAMINE; DELTA CONOTOXIN; INSECT VENOM; MU CONOTOXIN; NEUROTOXIN; NICOTINIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA AGATOXIN; OMEGA CONOTOXIN CVID; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIA; OPIATE DERIVATIVE; PEPTIDE DERIVATIVE; PHILANTHOTOXIN; PIPERIDINE DERIVATIVE; RHO CONOTOXIN; SCORPION VENOM; SNAIL VENOM; SNAKE VENOM; SPIDER VENOM; TAU CONOTOXIN; TOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLODYNIA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; CHRONIC PAIN; CLINICAL TRIAL; DRUG ACTIVITY; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG TOLERANCE; HUMAN; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TREATMENT OUTCOME;

ANIMALIA;

EID: 3042545911     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2005.04.002     Document Type: Erratum

References (174)

1. Aird S.D. Ophidian envenomation strategies and the role of purines. Toxicon. 40:(4):2002;335-393
2. Alonso D., Khalil Z., Satkunanthan N., Livett B.G. Drugs from the sea: conotoxins as drug leads for neuropathic pain and other neurological conditions (Mini Rev). Med. Chem. 3:(7):2003;785-787
3. Altman R.D., Schultz D.R., Collins-Yudiskas B., Aldrich J., Arnold P.I., Brown H.E. The effect of a partially purified fraction of ant venom in rheumatoid arthritis. Arthritis Rheum. 27:(3):1984;277-285
4. Avalos M., Parker M.J., Maddox F.N., Carroll F.I., Luetje C.W. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine. J. Pharmacol. Exp. Ther. 302:(3):2002;1246-1252
5. 2]-Deltorphin, a 17 amino acid opioid peptide from the skin of the Brazilian hylid frog, Phyllomedusa burmeisteri. Peptides. 15:(2):1994;199-202
6. Basso N., Marcelli M., Ginaldi A., De Marco M. Intrathecal dermorphin in post-operative analgesia. Peptides. 6:(Suppl. 3):1985;177-179
7. Belluardo N., Mudo G., Caniglia G., Cheng Q., Blum M., Fuxe K. The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions. Neuroreport. 10:(18):1999;3909-3913
8. Berman H.M., Westbrool J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucl. Acids Res. 28:2000;235-242
9. Bevan S., Yeats J. Protons activate a cation conductance in a sub-population of rat dorsal root ganglion neurons. J. Physiol. (Lond). 433:1991;145-161
10. 2 by PMS 832. J. Lipid. Med. Cell. Sig. 16:(3):1997;171-187
11. Borkow G., Gutierrez J.M., Ovadia M. A potent antihemorrhagin in the serum of the non-poisonous water snake Natrix tessellata: isolation, characterization and mechanism of neutralization. Biochim. Biophys. Acta. 1201:(3):1994;482-490
12. Bowersox S.S., Luther R. Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus. Toxicon. 36:(11):1998;1651-1658
13. Bowersox S.S., Gadbois T., Singh T., Pettus M., Wang Y.X., Luther R.R. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J. Pharmacol. Exp. Ther. 279:(3):1996;1243-1249
14. Bowersox S., Tich N., Mayo M., Luther R. SNX-111, a selective N-type voltage-sensitive calcium channel blocker: a new class of antinociceptive agent. Drugs Future. 23:(2):1998;152-160
15. Brazil O.V., Fontana M.D. Toxins as tools in the study of sodium channel distribution in the muscle fiber membrane. Toxicon. 31:(9):1993;1085-1098
16. Brennan F.M. Role of cytokines in experimental arthritis. Clin. Exp. Immunol. 97:(1):1994;1-3
17. Broccardo M., Erspamer V., Falconieri-Erspamer G., Improta G., Linari G., Melchiorri P., Montecucchi P.C. Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin. Br. J. Pharmacol. 73:(3):1981;625-631
18. Cameron D.L., Tu A.T. Chemical and functional homology of myotoxin A from prairie rattle-snake venom and crotamine from South American rattlesnake venom. Biochem. Biophys. Acta. 532:(1):1978;147-154
19. Chang Y.H., Bliven M.L. Anti-arthritic effects of bee venom. Agents Actions. 9:(2):1979;205-211
20. Chaplan S.R., Pogrel J.W., Yaksh T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J. Pharmacol. Exp. Ther. 269:(3):1994;1117-1123
21. Chapman V., Suzuki R., Dickenson A.H. Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves. L5-L6. J. Physiol. 507:(pt 3):1998;881-894
22. Chen B., Ji Y. Antihyperalgesia effect of BmK AS, a scorpion toxin, in rat by plantar injection. Brain Res. 952:(2):2002;322-326
23. Chen R., Robinson S.E. The effect of cholinergic manipulations on the analgesic response to cobrotoxin in mice. Life Sci. 47:(21):1990;1949-1954
24. Chen R., Robinson S.E. The effect of cobrotoxin on cholinergic neurons in the mouse. Life Sci. 51:(13):1992;1013-1019
25. Chen J., Luo C., Li H., Chen H. Primary hyperalgesia to mechanical and heat stimuli following subcutaneous bee venom injection into the plantar surface of hindpaw in the conscious rat: a comparative study with the formalin test. Pain. 83:(1):1999;67-76
26. Chen B., Wang C., Ji Y. Scorpion BmK venom induces nociceptive response of rats by plantar injection. Neurotoxicol. Teratol. 23:(6):2001;675-679
27. Chiba T., Murase H., Ambo A., Sasaki Y. Antinociceptive activity of deltorphin analogs in the formalin test. Life Sci. 59:(20):1996;1717-1722
28. Correa M.M., Sampio S.V., Lopes R.A., Mancuso L.C., Cunha O.A., Franco J.J., Giglio J.R. Biochemical and histopathological alterations induced in rats by Tityus serrulatus scorpion venom and its major neurotoxin tityustoxin-1. Toxicon. 35:(7):1997;1053-1067
29. Craig A.G., Norberg T., Griffin D., Hoeger C., Akhtar M., Schmidt L., Low W., Dykert J., Richelson E., Navaro V., Mazella J., Watkins M., Hillyard D., Imperial J., Cruz L.J., Olivera B.M. Contulakin-G, an O-glycosylated invertebrate neurotensin. J. Biol. Chem. 274:(20):1999;13752-13759
30. Decker M.W., Meyer M.D. Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics. Biochem. Pharmacol. 58:(6):1999;917-923
31. Decker M.W., Bannon A.W., Buckley M.J., Kim D.J., Holladay M.W., Ryther K.B., Lin N.H., Wasicak J.T., Williams M., Arneric S.P. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. Eur. J. Pharmacol. 346:(1):1998;23-33
32. Dempsey C.E. The actions of melittin on membranes. Biochim. Biophys. Acta. 1031:(2):1990;143-161
33. Dickenson A. The pharmacology of pain. Dickenson A.H., Besson J.M. Handbook of Experimental Pharmacology. 1997;167-210 Springer, Berlin
34. Drickamer K., Taylor M.E. Biology of animal lectins. Annu. Rev. Cell Biol. 9:1993;237-264
35. Drickamer K., Dordal M.S., Reynolds L. Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein. J. Biol. Chem. 261:(15):1986;6878-6887
36. 2 enzymes. Biochem. Biophys. Acta. 1533:(1):2001;29-37
37. Dutta A.S., Chaudhuri A.K. Neuropharmacological studies on the venom of Vipera russelli. Ind. J. Exp. Biol. 29:(10):1991;937-942
38. Dunn J.D., Killion J.J. Melittin-evoked increase in plasma corticosterone level. Life Sci. 43:(4):1988;335-343
39. Eiseman J.L., vonBredow J., Alvares A.P. Effect of honeybee (Apis mellifera) venom on the course of adjuvant-induced arthritis and depression of drug metabolism in the rat. Biochem. Pharmacol. 31:(6):1982;1139-1146
40. + channels. J. Biol. Chem. 275:(33):2000;25116-25121
41. 2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res. Bull. 49:(3):1999;139-153
42. 2. Biochimie. 82:(9-10):2000;833-840
43. 2 in the blood plasma of snakes. Toxicon. 40:(5):2002;481-484
44. Fortes-Dias C.L., Fonseca B.C., Kochva E., Dinez C.R. Purification and properties of an antivenom factor form the plasma of the South American rattlesnake (Crotalus durissus terrificus). Toxicon. 29:(8):1991;997-1008
45. Giorgi R., Bernardi M.M., Cury Y. Analgesic effect evoked by low molecular weight substances extracted from Crotalus durissus terrificus venom. Toxicon. 31:(10):1993;1257-1265
46. + current in nociceptors. Proc. Natl Acad. Sci. USA. 93:(3):1996;1108-1112
47. Goldenberg D.P., Koehn R.E., Gilbert D.E., Wagner G. Solution structure and backbone dynamics of an omega-conotoxin precursor. Protein Sci. 10:(3):2001;538-550
48. Goudet C., Chi C.W., Tytgat J. An overview of toxins and genes from the venom of the Asian scorpion Buthus martesi Karsch. Toxicon. 40:(9):2002;1239- 1258
49. Grishin E. Polypeptide neurotoxins from spider venoms. Eur. J. Biochem. 264:(2):1999;276-280
50. Gu J.G., MacDermott A.B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature. 389:(6652):1997;749-753
51. Guan R.J., Wang C.G., Wang M., Wang D.C. A depressant insect toxin with a novel analgesic effect from scorpion Buthus martensii Karsch. Biochim. Biophys. Acta. 1549:(1):2001;9-18
52. Guan R.J., Wang M., Wang D., Wang D.C. A new insect neurotoxin AngP1 with analgesic effect from the scorpion Buthus martensi Karsch: purification and characterization. J. Pept. Res. 58:(10):2001;27-35
53. 2 inhibitors from Australian elapid sera. Biochem. J. 346:(pt 1):2000;139-146
54. 2 inhibitor from Notechis ater serum. J. Biol. Chem. 275:(2):2000;983-991
55. 2-induced mouse paw edema models. Agents Actions. 34:(1-2):1991;84-88
56. Haux P. Amino acid sequence of MCD-peptide, a specific mast cell-degranualating peptide from bee venom. Hoppe-Seyler's Z. Physiol. Chem. 350:(5):1969;536-546
57. Heller A., Koch T., Schmeck J., van-Ackern K. Lipid mediators in inflammatory disorders. Drugs. 55:(4):1998;487-496
58. Hu L.Y., Ryder T.R., Rafferty M.F., Feng M.R., Lotarski S.M., Rock D.M., Sinz M., Stoehr S.J., Taylor C.P., Weber M.L., Bowersox S.S., Miljanich G.P., Millerman E., Wang Y.X., Szoke B.G. Synthesis of a series of 4-Benzyloxyanilline anlogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic properties. J. Med. Chem. 42:(20):1999;4239-4249
59. Improta G., Broccardo M. Spinal antinociceptive effects of [D-Ala2]-deltorphin II, a novel and highly selective delta-opioid receptor agonist. Peptides. 13:(6):1992;1123-1126
60. 2 inhibitors from the plasma of venomous snakes. Biochem. Mol. Biol. Int. 41:(3):1997;529-537
61. Jain K.K. Modulators of nicotinic acetylcholine receptors as analgesics. Curr. Opin. Investig. Drugs. 5:(1):2004;76-81
62. Jones M., Lodge D. Comparison of some arthropod toxins and toxin fragments as antagonists of excitatory amino acid-induced excitation of rat spinal neurons. Eur. J. Pharmacol. 204:(2):1991;203-209
63. Jones R.M., Cartier G.E., McIntosh J.M., Bulaj G., Farrar V.E., Olivera B.M. Composition and therapeutic utility of conotoxins from genus Conus. Patent status 1996-2000. Exp. Opin. Ther. Patents. 11:(4):2001;603-623
64. Kang S.S., Pak S.C., Choi S.H. The effect of whole bee venom on arthritis. Am. J. Chin. Med. 30:(1):2002;73-80
65. Kawai N., Miwa A., Shimazaki K., Sahara Y., Robinson H.P., Nakajima T. Spider toxin and the glutamate receptors. Comp. Biochem. Physiol. C. 98:(1):1991;87-95
66. 2 inhibitor in habu serum. J. Biochem. (Tokyo). 80:(2):1976;341-349
67. Kim J.I., Konishi S., Iwai H., Kohno T., Gouda H., Shimada I., Sato K., Arata Y. Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers. J. Mol. Biol. 250:(5):1995;659-671
68. Kim H.W., Kwon Y.B., Ham T.W., Roh D.H., Yoon S.Y., Lee H.J., Han H.J., Yang I.S., Beitz A.J., Lee J.H. Acupoint stimulation using bee venom attenuates formalin-induced pain behavior and spinal cord Fos expression. J. Vet. Med. Sci. 65:(3):2003;349-355
69. Klein R.C., Prorok M., Galdzicki Z., Castellino F.J. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. J. Biol. Chem. 276:(29):2001;26860-26867
70. Koburova K.L., Michailova S.G., Shkenderov S.V. Further investigation on the anti-inflammatory properties of adolapin-bee venom polypeptide. Acta Physiol. Pharmacol. Bulg. 11:(2):1985;50-55
71. Kochva E. The origin of snakes and evolution of the venom apparatus. Toxicon. 25:1987;65-106
72. 2 inhibitor from the blood plasma of Trimeresurus flavoviridis. J. Biochem. (Tokyo). 106:(6):1989;966-971
73. Kreil G., Barra D., Simmaco M., Erspamer V., Erspamer G.F., Negri L., Severini C., Corsi R., Melchiorri P. Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for δ-opioid receptors. Eur. J. Pharmacol. 162:(1):1989;123-128
74. Kwon Y.B., Lee J.D., Lee H.J., Han H.J., Mar W.C., Kang S.K., Beitz A.J., Lee J.H. Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain. 90:(3):2001;271-280
75. Kwon Y.B., Kim J.H., Yoon J.H., Lee J.D., Han H.J., Mar W.C., Beitz A.J., Lee J.H. The analgesic efficacy of bee venom acupuncture for knee osteoarthritis: a comparative study with needle acupuncture. Am. J. Med. Chin. 29:(2):2001;187-199
76. Kwon Y.B., Kang M.S., Han H.J., Beitz A.J., Lee J.H. Visceral antinociception produced by bee venom stimulation of the zhongwan acupuncture point in mice: role of alpha (2) adrenoceptors. Neurosci. Lett. 308:(2):2001;133-137
77. Kwon Y.B., Lee H.J., Han H.J., Mar W.C., Kang S.K., Yoon O.B., Beitz A.J., Lee J.H. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 71:(2):2002;191-204
78. Kwon Y.B., Kim H.W., Ham T.W., Yoon S.Y., Roh D.H., Han H.J., Beitz A.J., Yang I.S., Lee J.H. The anti-inflammatory effect of bee venom stimulation in a mouse air pouch model is mediated by adrenal medullary activity. J. Neuroendocrinol. 15:(1):2003;93-96
79. Labuz D., Chocyk A., Wedzony K., Toth G., Przewlocka B. Endorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord. Life Sci. 73:(4):2003;403-412
80. 2. Trends. Pharmacol. Sci. 20:(4):1999;162-170
81. 2. Toxicon. 38:(2):2000;199-208
82. Lariviere W.R., Melzack R. The bee venom test: a new tonic-pain test. Pain. 66:(2-3):1996;271-277
83. Lazarus L.H., Bryant S.D., Attila M., Salvadori S. Frog skin opioid peptides: a case for environmental mimicry. Environ. Health Perspect. 102:(8):1994;648-654
84. Leme J.G., Pimenta A.F., Raulino-Filho M., Diniz C.R. Sensory nerves and inflammation: evidence for the release of a neurogenic permeability factor by tityustoxin. J. Pathol. 124:(3):1978;165-176
85. Levine J.D., Reichling D.B. Peripheral mechanisms of inflammatory pain. Wall P.D., Melzack R. Textbook of Pain. 1999;59-61 Churchill Livingstone, Edinburg
86. Lewis R.J., Nielsen K.J., Craik D.J., Loughnan M.L., Adams D.A., Sharpe I.A., Luchian T., Adams D.J., Bond T., Thomas L., Jones A., Matheson J.L., Drinkwater R., Andrews P.R., Alewood P.F. Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J. Biol. Chem. 275:(45):2000;35335-35344
87. Liu Y.F., Ma R.L., Wang S.L., Duan Z.Y., Zhang J.H., Wu L.J., Wu C.F. Expression of an antitumor-analgesic peptide from the venom of Chinese scorpion Buthus martensi Karsch in Escherichia coli. Protein Expr Purif. 27:(2):2003;253-258
88. 2 myotoxin inhibitor from the plasma of the snake Bothrops asper. Biochem. J. 326:(pt 3):1997;853-859
89. Lizano S., Angulo Y., Lomonte B., Fox J.W., Lambeau G., Lazdunski M., Gutierrez J.M. Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties. Biochem. J. 346:(pt 3):2000;631-639
90. Malcangio M., Bowery N.G. GABA and its receptors in the spinal cord. TIPS. 17:1996;457-462
91. Malmberg A.B., Yaksh T.L. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N-and P-type channels inhibits formalin-induced nociception. J. Neurosci. 14:1994;4882-4890
92. Malmberg A.B., Gilbert H., McCabe R.T., Basbaum A.I. Powerful antinociceptive effects of the cone snail venom-derived sub-type-selective NMDA receptor antagonists conantokins G and T. Pain. 101:(1-2):2003;109-116
93. Mancin A.C., Soares M., Andriao-Escarso S.H., Faca A.M., Green L.J., Zuccolotto S., Pela I.R., Giglio J.R. The analgesic activity of crotamine, a neurotoxin from Crotalus durissus terrificus (South American Ratttle snake) venom: a biochemical and pharmacological study. Toxicon. 36:(12):1998;1927-1937
94. Martin W., Hartter P. Basic peptides in bee venom, VI. Structure-activity studies on the anti-inflammatory effects of derivatives and fragments of the MCD-peptide. Hoppe-Seyler's Z. Physiol. Chem. 361:(4):1980;525-535
95. Matthews E.A., Dickenson A.H. Effects of spinally delivered N- and P- type voltage dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain. 92:(1-2):2001;235-246
96. McCleskey E.W., Gold M.S. Ion channels and nociception. Annu. Rev. Physiol. 61:1999;835-856
97. McIntosh J.M., Jones R.M. Cone venom: from accidental stings to deliberate injection. Toxicon. 39:(10):2001;1447-1451
98. McIntosh J.M., Corpuz G.O., Layer R.T., Garrett J.E., Wagstaff J.D., Bulaj G., Vyazovkina A., Yoshikami D., Cruz L.J., Olivera B.M. Isolation and characterization of a Novel Conus Peptide with apparent antinociceptive activity. J. Biol.Chem. 275:(42):2000;32391-32397
99. Menzler S., Bikker J.A., Suman-Chauhan N., Horwell D.C. Design and biological evaluation of non-peptide analogues of omega-conotoxin MVIIA. Bioorg. Med. Chem. Lett. 10:(4):2000;345-347
100. Meyer M.D., Decker M.W., Rueter L.E., Anderson D.J., Dart M.J., Kim K.H., Sullivan J.P., Williams M. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain. Eur. J. Pharmacol. 393:(1-3):2000;171-177
101. Minz I.M., Adams M.E., Bean B.P. P-type calcium channels in rat central and peripheral neurons. Neuron. 9:1992;85-95
102. Mintz I.M., Venema V.J., Swiderek K.M., Lee T.D., Bean B.P., Adams M.E. P-type calcium channels blocked by the spider toxin ω-aga-IVA. Nature. 355:(6363):1992;827-829
103. Montecucchi P.C., de Castiglione R., Erspamer V. Identification of dermorphin and Hyp-dermorphin in skin extracts of the Brazilian frog Phyllomedusa rohdeii. Int. J. Peptide Protein Res. 17:(3):1981;316-321
104. Mor A., Delfour A., Amiche M., Sagan S., Nicolas P., Grassi J., Pradelles P. Dermorphin and related peptides in rat tissues. Neuropeptides. 13:(1):1989;51-57
105. Naim M., Charpentier S., Nicolas P., Baron D. Quantitative two-dimensional NMR study of dermenkephalin, a highly potent and selective delta-opioid peptide. Biopolymers. 33:(12):1993;1889-1900
106. Nam K.W., Je K.H., Lee J.H., Han H.J., Lee H.J., Kang S.K., Mar W. Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera). Arch. Pharm. Res. 26:(5):2003;383-388
107. Nebe J., Vanegas H., Neugebauer V., Schaible H.G. ω-agatoxin IVA, a P-type calcium channel antagonist, reduces nociceptive processing in spinal cord neurons with input from the inflamed but not from the normal knee joint - an electrophysiological study in the rat in vivo. Eur. J. Neurosci. 9:(10):1997;2193-2201
108. Negri L., Erspamer G.F., Severini C., Potenza R.L., Melchiorri P., Erspamer V. Dermorphin related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two μ-opioid receptor subtypes, which modulate antinociception and catalepsy in the rat. Proc. Natl Acad. Sci. USA. 89:(15):1992;7203-7207
109. Negri L., Lattanzi R., Tabacco F., Scolaro B., Rocchi R. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration. Br. J. Pharmacol. 124:(7):1998;1516-1522
110. 2 in inflammatory diseases. Clin. Chem. 39:(12):1993;2453-2459
111. Nicol G.D., Vasko M.R., Evans A.R. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons. J. Neurophysiol. 77:(1):1997;167-176
112. Nishiyama T., Gyermek L., Trudell M.L., Hanaoka K. Spinally mediated analgesia and receptor binding affinity of epibatidine analogs. Eur. J. Pharmacol. 470:(1-2):2003;27-31
113. 2 isozymes in the snake venom. Eur. J. Biochem. 249:(3):1997;838-845
114. 2 inhibitor from the blood plasma of the Thailand cobra Naja naja kaouthia. Biochem. Biophys. Res. Commun. 200:(2):1994;784-788
115. 2 inhibitor from the plasma of Thailand cobra having structural similarity to urokinase-type plasminogen activator receptor and LY-6 related proteins Biochem. Biophys. Res. Commun. 204:(3):1994;1212-1218
116. 2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffii siniticus. Biochem. J. 325:(pt 2):1997;527-531
117. 2 inhibitor from the blood plasma of the Sea Krait, Laticauda semifasciata. J. Biochem. 125:(2):1999;375-382
118. 2 inhibitor with leucine-rich repeats from the blood plasma of Agkistrodon blomhoffii siniticus: sequence homologies with human leucine-rich α2-glycoprotein. J. Biol. Chem. 273:(31):1998;19469-19475
119. 2 inhibitor from the serum of the non-venomous snake Elaphe quadrivirgata. Biochem. J. 341:(1):1999;165-171
120. Okumura K., Inoue S., Ikeda K., Hayashi K. Identification of beta-type phospholipase A(2) inhibitor in a nonvenomous snake, Elaphe quadrivirgata. Arch. Biochem. Biophys. 408:(1):2002;124-130
121. Olivera B.M., Cruz L.J. Conotoxins, in retrospect. Toxicon. 39:2001;7-14
122. Olivera B.M., Cruz L.J., de Santos V., Lecheminant G.W., Griffin D., Zeikus R.D., McIntosh J.M., Galyean R., Varga J., Gray W.R., Rivier J.E. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry. 26:(8):1987;2086-2090
123. Pan J., Hink W.F. Isolation and characterization of myrmexins, six isoforms of venom proteins with anti-inflammatory activity from the tropical ant, Pseumyrmex triplarinus. Toxicon. 38:(10):2000;1403-1413
124. Perales J., Villela C., Domont G.B., Choumet V., Saliou B., Moussatche H., Bon C., Faure G. Molecular structure and mechanism of action of the crotoxin inhibitor from Crotalus durissus terrificus serum. Eur. J. Biochem. 227:(1-2):1995;19-26
125. Picolo G., Giorgi R., Cury Y. δ-opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom. Eur. J. Pharmacol. 391:(1-2):2000;55-62
126. + channels mediates the anitnociceptive effect of Crotalus durissus terrificus snake venom. Eur. J. Pharmacol. 469:(1-3):2003;57-64
127. Pirec V., Laurito C.E., Lu Y., Yeomans D.C. The combined effects of N-type calcium channel blockers and morphine on A delta versus C fiber mediated nociception. Anesth. Anal. 92:(1):2001;239-243
128. Pleuvry B.J., Lauretti G.R. Biochemical aspects of chronic pain and its relationship to treatment. Pharmacol. Ther. 71:(3):1996;313-324
129. Plummer M.R., Logothetis D.E., Hess P. Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron. 2:(5):1989;1453-1463
130. Prado W.A. Involvement of calcium in pain and antinociception. Braz. J. Med. Biol. Res. 34:(4):2001;449-461
131. Pu X.C., Wong P.T., Gopalakrishnakone P. A novel analgesic toxin (Hannalgesin) from the venom of king cobra (Ophiophagus hannah). Toxicon. 33:(11):1995;1425-1431
132. Rash L.D., Hodgson W.C. Pharmacology and biochemistry of spider venoms. Toxicon. 40:(3):2002;225-254
133. Reddy S.V., Yaksh T.L. Antinociceptive effects of lanthanum, neodymium and europium following intrathecal administration. Neuropharmacology. 19:1980;181-185
134. Reisine T., Pasternak G. Opioid analgesics and antagonists. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. Goodman and Gilman's The Pharmacological Basis of Therapeutics. Ninth ed. 1996;521-555 McGraw-Hill, New York
135. Riedel W., Neeck G. Nociception, pain, and anti-nociception: current concepts. Z. Rheumatol. 60:(6):2001;404-415
136. Roerig S.C., Howse M. ω-blocks spinal morphine/clonidine antinociceptive synergism. Eur. J. Pharmacol. 314:(3):1996;293-300
137. 2 and inhibits its enzymatic activity. Biochem. Biophys. Res. Commun. 238:(2):1997;436-442
138. Sandrini G., Degli Uberti E., Salvadori S., Margutti A., Trasforini G., Tomatis R., Nappi G., Pansini R. Dermorphin inhibits spinal nociceptive flexion reflex in humans. Brain Res. 371:(2):1986;364-367
139. Schultz D.R., Arnold P.I. Immunochemical and clinical studies of venom from the ant Pseudomyrmex sp. Tu A.T. Handbook of Natural Toxins, Insect Poisons, Allergens and Other Invertebrate Venoms. vol. 2:1984;243-290 Marcel Dekker, New York
140. Scott S., Bowersox S.S., Luther R. Pharmacotherapeutic potential of Omega-conotoxin MVII A (SNX-111): an N-type neuronal calcium channel blocker found in the venom of Conus magus. 36:(11):1998;1651-1658
141. 2 in arthritic synovial fluid. J. Biochem. (Tokyo). 106:(1):1989;38-42
142. Shen G.S., Layer R.T., McCabe R.T. Conopeptides: from deadly venoms to novel therapeutics. Drug Discover. Today. 5:(3):2000;98-105
143. Shkenderov S., Koburova K. Adolapin - a newly isolated analgetic and anti-inflammatory polypeptide from bee venom. Toxicon. 20:(1):1982;317-321
144. Sluka K.A. Blockade of N- and P/Q-type calcium channels reduces the secondary heat hyperalgesia induced by acute inflammation. J. Pharmacol. Exp. Ther. 287:(1):1998;232-237
145. 2 myotoxin inhibitor protein from Bothrops moojeni snake venom. Biochem. Biophys. Res. Commun. 302:(2):2003;193-200
146. Somerfield S.D., Stach J.L., Mraz C., Gervais F., Skamene E. Bee venom inhibits superoxide production by human neutrophils. Inflammation. 8:(4):1984;385-391
147. 2- production. Inflammation. 10:(2):1986;175-182
148. 2+ permeable AMPA receptor antagonist. Neuroreport. 10:(17):1999;3523-3526
149. 2+-permeable non-NMDA glutamate receptor antagonists. Anesthesiology. 95:(4):2001;965-975
150. Spande T.F., Garraffo H.M., Yeh H.J., Pu Q.L., Pannell L.K., Daly J.W. A new class of alkaloids from a dendrobatid poison frog: a structure for alkaloid 251F. J. Nat. Prod. 55:(6):1992;707-722
151. 2+- permeable non-NMDA glutamate receptors in spinal nociceptive transmission. Neuroreport. 11:(14):2000;3199-3202
152. Suh H.W., Song D.K., Choi S.R., Huh S.O., Kim Y.H. Differential effects of ω-Conotoxin GVIA, Nimodipine, Calmidazolium and KN-62 injected intrathecally on the antinociception induced by beta-endorphin, Morphine and [D-Ala2, N-MePhe4, Gly-ol5]-enkephalin administered intracerebroventricularly in the mouse. J. Biol. Chem. 282:(2):1997;961-966
153. Sullivan J., Decker M.W., Brioni J.D., Donnelly-Roberts D., Anderson D.J., Bannon A.W., Kang C.H., Adams P., Piattoni-Kaplan M., Buckley M.J., Gopalakrishnan M., Williams M., Arneric S.P. (±) Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 271:(2):1994;624-631
154. Suzuki R., Dickenson A. Neuropathic pain: nerves bursting with excitement. Neuroreport. 11:(12):2000;R17-R21
155. Suzuki R., Stanfa L., Kowaluk E., Williams M., Jarvis M., Dickenson A. The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurons following carrageenin inflammation and peripheral nerve injury. Br. J. Pharmacol. 132:(7):2001;1615-1623
156. Tan Z.Y., Xiao H., Mao X., Wang C.Y., Zhao Z.Q., Ji Y.H. The inhibitory effects of BmK IT2, a scorpion neurotoxin on rat nociceptive flexion reflex and a possible mechanism for modulating voltage-gated Na (+) channels. Neuropharmacology. 40:(3):2001;352-357
157. + currents in dorsal root ganglion neurons. Neurosci. Lett. 297:(2):2001;65-68
158. 2 inhibition and venom neutralizing potential. Biochemistry. 39:(31):2000;9604-9611
159. Thwin M.M., Satish R.L., Chan S.T., Gopalakrishnakone P. Functional site of endogenous phospholipase A2 inhibitor from python serum. Eur. J. Biochem. 269:(2):2002;719-727
160. Tripathi H.L., Martin B.R., Aceto M.D. Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels. J. Pharmacol. Exp. Ther. 221:(1):1982;91-96
161. Vega T., De Pascual R., Bulbena O., Garcia A.G. Effects of omega-toxins on noradrenergic neurotransmission in beating guinea-pig atria. Eur. J. Pharmacol. 276:(3):1995;231-238
162. Waldmann R., Champigny G., Bassilana F., Heurteaux C., Lazdunski M. A proton-gated channel involved in acid sensing. Nature. 386:(6621):1997;173-177
163. Waldmann R., Champigny G., Lingueglia E., Weille D. Jr., Heurteaux C., Lazdunski M. H(+)-gated cation channels. Ann. NY Acad. Sci. 868:1999;67-76
164. Wang Y.X., Bezprozvannaya S., Bowersox S.S., Nadsdi L., Miljanich G.,
165. Wang Y.X., Pettus M., Gao D., Phillips C., Scott Bowersox S. Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain. Pain. 84:(2-3):2000;151-158
166. Waxman S.G., Kocsis J.D., Black J.A. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons and is reexpressed following axotomy. J. Neurophysiol. 72:(1):1994;466-470
167. White R.T., Damm D., Miller J., Spratt K., Schilling J., Hawgood S., Benson B., Cordell B. Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature. 317:(6035):1985;361-363
168. Winter C.A., Risley E.A., Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. 111:1962;544-546
169. Xiong Y.M., Lan Z.D., Wang M., Liu B., Liu X.Q., Fei H., Xu L.G., Xia Q.C., Wang C.G., Wang D.C., Chi C.W. Molecular characterization of a new excitatory insect neurotoxin with an analgesic effect on mice from the scorpion Buthus martensi Karsch. Toxicon. 37:(8):1999;1165-1180
170. Yamamoto T., Sakashita Y. Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. Brain Res. 794:(2):1998;329-332
171. 2 as a therapeutic target. Biochim. Biophys. Acta. 1488:(1-2):2000;182-187
172. Yu C., Bhaskaran R., Chuang L.C., Yang C.C. Solution conformation of cobrotoxin: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. Biochemistry. 32:(9):1993;2131-2136
173. Zetler G. Caerulein and its anlogues: neuropharmacological properties. Peptides. 6:(Suppl 3):1985;33-46
174. Zlotkin E., Miranda F., Rochat H. Chemistry and pharmacology of Buthinae scorpion venoms. Bettini S. Handbook of Experimental Physiology. vol. 48:1978;Springer, Heidelberg